https://si.prisysbiotech.com/ Ne - Človek Primat Raziskovanje Platforma & CRO | PRISYS Biotehnologija https://si.prisysbiotech.com/uploads/39406/logo.png https://si.prisysbiotech.com/translation-research/ Prevajalske raziskave https://si.prisysbiotech.com/uploads/202339406/p202303211454114300368.jpg https://si.prisysbiotech.com/safety-evaluation/ Varnostna ocena https://si.prisysbiotech.com/uploads/202339406/p202303211451568197109.jpg https://si.prisysbiotech.com/biosafety-research/ Raziskave biološke varnosti https://si.prisysbiotech.com/uploads/202339406/p202303211456214933321.jpg https://si.prisysbiotech.com/nhp-pharmacology/ Farmakologija NHP https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/pk-pd-adme/ PK PD ADME https://si.prisysbiotech.com/uploads/202339406/p202303211449418813566.jpg https://si.prisysbiotech.com/safety-evaluation/dose-range-finding-test.html Dose Range Finding Test https://si.prisysbiotech.com/uploads/39406/page/small/dose-range-finding-test1c040.png Dose Range Finding Test https://si.prisysbiotech.com/uploads/39406/page/dose-range-finding-test1c040.png https://si.prisysbiotech.com/pk-pd-adme/toxicokinetics.html Toxicokinetics https://si.prisysbiotech.com/uploads/39406/page/small/toxicokinetics7dc92.png Toxicokinetics https://si.prisysbiotech.com/uploads/39406/page/toxicokinetics7dc92.png https://si.prisysbiotech.com/nhp-pharmacology/the-nhp-pharmacology-of-prisys.html The NHP Pharmacology Of Prisys https://si.prisysbiotech.com/uploads/39406/page/small/the-nhp-pharmacology-of-prisysb465a.jpg The NHP Pharmacology Of Prisys https://si.prisysbiotech.com/uploads/39406/page/the-nhp-pharmacology-of-prisysb465a.jpg https://si.prisysbiotech.com/nhp-pharmacology/what-is-a-nhp-study.html What Is A NHP Study https://si.prisysbiotech.com/uploads/39406/small/what-is-a-nhp-study7f0f9.jpg What Is A NHP Study https://si.prisysbiotech.com/uploads/39406/what-is-a-nhp-study7f0f9.jpg https://si.prisysbiotech.com/safety-evaluation/single-dose-repeated-dose-toxicity-testing.html Single-dose & Repeated Dose Toxicity Testing https://si.prisysbiotech.com/uploads/39406/single-dose-repeated-dose-toxicity-testinga0b95.jpg Single-dose & Repeated Dose Toxicity Testing https://si.prisysbiotech.com/uploads/39406/single-dose-repeated-dose-toxicity-testinga0b95.jpg https://si.prisysbiotech.com/nhp-pharmacology/non-human-primate-model-renal-ischemia.html Non-Human Primate Model Renal Ischemia Reperfusion Injury (AKI To CKD Transition) https://si.prisysbiotech.com/uploads/202339406/small/non-human-primate-model-renal-ischemia7ddb4a21-f360-4251-a51c-3cdb367eb3ad.jpg Non-Human Primate Model Renal Ischemia Reperfusion Injury (AKI To CKD Transition) https://si.prisysbiotech.com/uploads/202339406/non-human-primate-model-renal-ischemia7ddb4a21-f360-4251-a51c-3cdb367eb3ad.jpg https://si.prisysbiotech.com/pk-pd-adme/pharmacokinetics.html Pharmacokinetics https://si.prisysbiotech.com/uploads/39406/page/small/pharmacokinetics6a507.png Pharmacokinetics https://si.prisysbiotech.com/uploads/39406/page/pharmacokinetics6a507.png https://si.prisysbiotech.com/biosafety-research/biosafetyresearch.html Biosafety Research https://si.prisysbiotech.com/uploads/39406/page/small/biosafetyresearchcd745.jpg Biosafety Research https://si.prisysbiotech.com/uploads/39406/page/biosafetyresearchcd745.jpg https://si.prisysbiotech.com/nhp-pharmacology/coagulation-hemostasis-nonhuman-primates.html Coagulation/Hemostasis Nonhuman Primates Disease Model https://si.prisysbiotech.com/uploads/202339406/small/coagulation-hemostasis-nonhuman-primates63c5ab02-c0b4-4eb9-b521-9658b5017498.jpg Coagulation/Hemostasis Nonhuman Primates Disease Model https://si.prisysbiotech.com/uploads/202339406/coagulation-hemostasis-nonhuman-primates63c5ab02-c0b4-4eb9-b521-9658b5017498.jpg https://si.prisysbiotech.com/safety-evaluation/toxicology.html Toxicology https://si.prisysbiotech.com/uploads/39406/toxicologycdb96.jpg Toxicology https://si.prisysbiotech.com/uploads/39406/toxicologycdb96.jpg https://si.prisysbiotech.com/nhp-pharmacology/nhp-lung-fibrosis-model.html NHP Lung Fibrosis Model https://si.prisysbiotech.com/uploads/39406/nhp-lung-fibrosis-model25cd4.jpg NHP Lung Fibrosis Model https://si.prisysbiotech.com/uploads/39406/nhp-lung-fibrosis-model25cd4.jpg https://si.prisysbiotech.com/nhp-pharmacology/hemophilia-a-nonhuman-primates-disease-model.html Hemophilia A Nonhuman Primates Disease Model https://si.prisysbiotech.com/uploads/202339406/small/hemophilia-a-nonhuman-primates-disease-model4c747716-98c5-4ef0-a508-55e7790a46ff.jpg Hemophilia A Nonhuman Primates Disease Model https://si.prisysbiotech.com/uploads/202339406/hemophilia-a-nonhuman-primates-disease-model4c747716-98c5-4ef0-a508-55e7790a46ff.jpg https://si.prisysbiotech.com/nhp-pharmacology/heart-failure-nonhuman-primates-disease-model.html NHP Acute Myocardial Infarction (AMI) Model https://si.prisysbiotech.com/uploads/39406/heart-failure-nonhuman-primates-disease-modela7712.png NHP Acute Myocardial Infarction (AMI) Model https://si.prisysbiotech.com/uploads/39406/heart-failure-nonhuman-primates-disease-modela7712.png https://si.prisysbiotech.com/nhp-pharmacology/nhp-non-alcoholic-steatohepatitis-nash-model.html NHP Non-Alcoholic Steatohepatitis (NASH) Model https://si.prisysbiotech.com/uploads/39406/page/small/nhp-non-alcoholic-steatohepatitis-nash-modelbd73a.png NHP Non-Alcoholic Steatohepatitis (NASH) Model https://si.prisysbiotech.com/uploads/39406/page/nhp-non-alcoholic-steatohepatitis-nash-modelbd73a.png https://si.prisysbiotech.com/pk-pd-adme/adme.html ADME https://si.prisysbiotech.com/uploads/39406/adme55f5d.jpg ADME https://si.prisysbiotech.com/uploads/39406/adme55f5d.jpg https://si.prisysbiotech.com/nhp-pharmacology/glaucoma-nonhuman-primates-disease-model.html Glaucoma Nonhuman Primates Disease Model https://si.prisysbiotech.com/uploads/39406/page/small/glaucoma-nonhuman-primates-disease-model1d4d5.png Glaucoma Nonhuman Primates Disease Model https://si.prisysbiotech.com/uploads/39406/page/glaucoma-nonhuman-primates-disease-model1d4d5.png https://si.prisysbiotech.com/translation-research/nhpresources.html NHP Resources https://si.prisysbiotech.com/uploads/39406/page/small/nhpresources90325.jpg NHP Resources https://si.prisysbiotech.com/uploads/39406/page/nhpresources90325.jpg https://si.prisysbiotech.com/safety-evaluation/new-and-modified-applications.html New And Modified Applications https://si.prisysbiotech.com/uploads/39406/page/small/new-and-modified-applicationsde315.png New And Modified Applications https://si.prisysbiotech.com/uploads/39406/page/new-and-modified-applicationsde315.png https://si.prisysbiotech.com/nhp-pharmacology/myopia-hyperopia-nhp-model.html Myopia Hyperopia Nonhuman Primates Disease Model https://si.prisysbiotech.com/uploads/39406/page/small/myopia-hyperopia-nhp-model745fb.png Myopia Hyperopia Nonhuman Primates Disease Model https://si.prisysbiotech.com/uploads/39406/page/myopia-hyperopia-nhp-model745fb.png https://si.prisysbiotech.com/nhp-pharmacology/amd-nonhuman-primates-disease-model.html AMD Nonhuman Primates Disease Model https://si.prisysbiotech.com/uploads/39406/page/small/amd-nonhuman-primates-disease-model78627.png AMD Nonhuman Primates Disease Model https://si.prisysbiotech.com/uploads/39406/page/amd-nonhuman-primates-disease-model78627.png https://si.prisysbiotech.com/translation-research/translational-studies.html Translational Studies https://si.prisysbiotech.com/uploads/39406/page/small/translational-studies5e517.png Translational Studies https://si.prisysbiotech.com/uploads/39406/page/translational-studies5e517.png https://si.prisysbiotech.com/nhp-pharmacology/nhp-asthma-atopic-dermatitis-model.html NHP Asthma/atopic Dermatitis Model https://si.prisysbiotech.com/uploads/39406/page/small/nhp-asthma-atopic-dermatitis-model85f50.png NHP Asthma/atopic Dermatitis Model https://si.prisysbiotech.com/uploads/39406/page/nhp-asthma-atopic-dermatitis-model85f50.png https://si.prisysbiotech.com/nhp-pharmacology/embolism-nonhuman-primates-disease-model.html Pulmonary Artery Hypertension/Embolism Nonhuman Primates Disease Model https://si.prisysbiotech.com/uploads/39406/page/small/embolism-nonhuman-primates-disease-model4e2cf.png Pulmonary Artery Hypertension/Embolism Nonhuman Primates Disease Model https://si.prisysbiotech.com/uploads/39406/page/embolism-nonhuman-primates-disease-model4e2cf.png https://si.prisysbiotech.com/nhp-pharmacology/nhp-chronic-obstructive-pulmonary-disease.html NHP Chronic Obstructive Pulmonary Disease (COPD) Model https://si.prisysbiotech.com/uploads/39406/page/small/nhp-chronic-obstructive-pulmonary-disease1524e.png NHP Chronic Obstructive Pulmonary Disease (COPD) Model https://si.prisysbiotech.com/uploads/39406/page/nhp-chronic-obstructive-pulmonary-disease1524e.png https://si.prisysbiotech.com/nhp-pharmacology/nhp-monkey-disease-models.html NHP(monkey) Disease Models https://si.prisysbiotech.com/uploads/39406/nhp-monkey-disease-models0f6a0.png NHP(monkey) Disease Models https://si.prisysbiotech.com/uploads/39406/nhp-monkey-disease-models0f6a0.png https://si.prisysbiotech.com/nhp-pharmacology/delayed-type-hypersensitivity-dth-nonhuman.html Delayed-type Hypersensitivity (DTH) Nonhuman Primates Disease Model https://si.prisysbiotech.com/uploads/39406/page/small/delayed-type-hypersensitivity-dth-nonhuman90003.jpg Delayed-type Hypersensitivity (DTH) Nonhuman Primates Disease Model https://si.prisysbiotech.com/uploads/39406/page/delayed-type-hypersensitivity-dth-nonhuman90003.jpg https://si.prisysbiotech.com/nhp-pharmacology/psoriasis-nonhuman-primates-disease-model.html Psoriasis Nonhuman Primates Disease Model https://si.prisysbiotech.com/uploads/39406/page/small/psoriasis-nonhuman-primates-disease-model6e94c.jpg Psoriasis Nonhuman Primates Disease Model https://si.prisysbiotech.com/uploads/39406/page/psoriasis-nonhuman-primates-disease-model6e94c.jpg https://si.prisysbiotech.com/nhp-pharmacology/tdar-nonhuman-primates-disease-model.html T Cell Dependent Antibody Response(TDAR) Nonhuman Primates Disease Model https://si.prisysbiotech.com/uploads/39406/page/small/tdar-nonhuman-primates-disease-modelae31c.jpg T Cell Dependent Antibody Response(TDAR) Nonhuman Primates Disease Model https://si.prisysbiotech.com/uploads/39406/page/tdar-nonhuman-primates-disease-modelae31c.jpg https://si.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-nhp-disease-model.html Inflammatory Bowel Disease Nonhuman Primates Disease Model https://si.prisysbiotech.com/uploads/39406/page/small/inflammatory-bowel-nhp-disease-modela21ae.png Inflammatory Bowel Disease Nonhuman Primates Disease Model https://si.prisysbiotech.com/uploads/39406/page/inflammatory-bowel-nhp-disease-modela21ae.png https://si.prisysbiotech.com/nhp-pharmacology/rheumatoid-arthritis-nhp-model.html Rheumatoid Arthritis Nonhuman Primates Disease Model https://si.prisysbiotech.com/uploads/39406/page/small/rheumatoid-arthritis-nhp-model438fa.jpg Rheumatoid Arthritis Nonhuman Primates Disease Model https://si.prisysbiotech.com/uploads/39406/page/rheumatoid-arthritis-nhp-model438fa.jpg https://si.prisysbiotech.com/nhp-pharmacology/uveitis-nonhuman-primates-disease-model.html Uveitis Nonhuman Primates Disease Model https://si.prisysbiotech.com/uploads/39406/page/small/uveitis-nonhuman-primates-disease-modele962a.png Uveitis Nonhuman Primates Disease Model https://si.prisysbiotech.com/uploads/39406/page/uveitis-nonhuman-primates-disease-modele962a.png https://si.prisysbiotech.com/pk-pd-adme/pharmacodynamics.html Pharmacodynamics https://si.prisysbiotech.com/uploads/39406/pharmacodynamics620d3.jpg Pharmacodynamics https://si.prisysbiotech.com/uploads/39406/pharmacodynamics620d3.jpg https://si.prisysbiotech.com/nhp-pharmacology/multiple-sclerosis-nhp-model.html Multiple Sclerosis Nonhuman Primates Disease Model https://si.prisysbiotech.com/uploads/202339406/multiple-sclerosis-nhp-modelac9f75fb-b6ef-46d4-867c-1ad7b769490b.jpg Multiple Sclerosis Nonhuman Primates Disease Model https://si.prisysbiotech.com/uploads/202339406/multiple-sclerosis-nhp-modelac9f75fb-b6ef-46d4-867c-1ad7b769490b.jpg https://si.prisysbiotech.com/safety-evaluation/immunotoxicity.html Immunotoxicity Testing and NHP Drug Safety Evaluation https://si.prisysbiotech.com/uploads/39406/small/immunotoxicity35901.jpg Immunotoxicity Testing and NHP Drug Safety Evaluation https://si.prisysbiotech.com/uploads/39406/immunotoxicity35901.jpg https://si.prisysbiotech.com/nhp-pharmacology/epilepsy-nhp-model.html Epilepsy Nonhuman Primates Disease Model https://si.prisysbiotech.com/uploads/39406/page/small/epilepsy-nhp-model4f142.jpg Epilepsy Nonhuman Primates Disease Model https://si.prisysbiotech.com/uploads/39406/page/epilepsy-nhp-model4f142.jpg https://si.prisysbiotech.com/nhp-pharmacology/neuropathic-pain-nhp-model.html Neuropathic Pain Nonhuman Primates Disease Model https://si.prisysbiotech.com/uploads/39406/page/small/neuropathic-pain-nhp-model48d12.png Neuropathic Pain Nonhuman Primates Disease Model https://si.prisysbiotech.com/uploads/39406/page/neuropathic-pain-nhp-model48d12.png https://si.prisysbiotech.com/nhp-pharmacology/mcao-nhp-model.html Middle Cerebral Artery Occlusion (MCAO) NHP Model Of Stoke & Brain Ischemia https://si.prisysbiotech.com/uploads/202339406/mcao-nhp-model0cf8cbb0-48b5-473b-b725-fd749c9c69ca.jpg Middle Cerebral Artery Occlusion (MCAO) NHP Model Of Stoke & Brain Ischemia https://si.prisysbiotech.com/uploads/202339406/mcao-nhp-model0cf8cbb0-48b5-473b-b725-fd749c9c69ca.jpg https://si.prisysbiotech.com/nhp-pharmacology/non-human-primate.html Non-Human Primate (NHP) https://si.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg Non-Human Primate (NHP) https://si.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg https://si.prisysbiotech.com/clearpoint/clearpoint-navigation-for-cns-research.html ClearPoint Navigation For CNS Research https://si.prisysbiotech.com/uploads/39406/page/small/clearpoint-navigation-for-cns-researchf4cb9.jpg ClearPoint Navigation For CNS Research https://si.prisysbiotech.com/uploads/39406/page/clearpoint-navigation-for-cns-researchf4cb9.jpg https://si.prisysbiotech.com/translation-research/ai-based-nhp-behavior-analysis-system.html AI-based NHP Behavior Analysis System https://si.prisysbiotech.com/uploads/39406/ai-based-nhp-behavior-analysis-systema5d80.png AI-based NHP Behavior Analysis System https://si.prisysbiotech.com/uploads/39406/ai-based-nhp-behavior-analysis-systema5d80.png https://si.prisysbiotech.com/nhp-pharmacology/parkinson-s-disease-model.html Parkinson's Disease Model https://si.prisysbiotech.com/uploads/39406/page/small/parkinson-s-disease-model9ce85.jpg Parkinson's Disease Model https://si.prisysbiotech.com/uploads/39406/page/parkinson-s-disease-model9ce85.jpg https://si.prisysbiotech.com/translation-research/clinical-imaging.html Klinično slikanje https://si.prisysbiotech.com/uploads/39406/clinical-imaging585d0.jpg Klinično slikanje https://si.prisysbiotech.com/uploads/39406/clinical-imaging585d0.jpg Clinical Imaging https://si.prisysbiotech.com/uploads/202439406/small/clinical-imagingb514bd15-133f-4e9b-a75a-0e1cbbc1f4f0.jpg Clinical Imaging https://si.prisysbiotech.com/uploads/202439406/clinical-imagingb514bd15-133f-4e9b-a75a-0e1cbbc1f4f0.jpg Clinical Imaging https://si.prisysbiotech.com/uploads/202439406/small/clinical-imagingb9ae57aa-6754-41ce-822c-46e3f1c3d84a.jpg Clinical Imaging https://si.prisysbiotech.com/uploads/202439406/clinical-imagingb9ae57aa-6754-41ce-822c-46e3f1c3d84a.jpg Clinical Imaging https://si.prisysbiotech.com/uploads/202439406/small/clinical-imaginga1e6f856-06fb-4365-aa1c-53949acb37af.jpg Clinical Imaging https://si.prisysbiotech.com/uploads/202439406/clinical-imaginga1e6f856-06fb-4365-aa1c-53949acb37af.jpg Clinical Imaging https://si.prisysbiotech.com/uploads/202439406/small/clinical-imagingb127b97f-7b00-4335-b905-64e36f57247d.jpg Clinical Imaging https://si.prisysbiotech.com/uploads/202439406/clinical-imagingb127b97f-7b00-4335-b905-64e36f57247d.jpg https://si.prisysbiotech.com/nhp-pharmacology/immunosuppression-model.html Immunosuppression Model https://si.prisysbiotech.com/uploads/39406/page/small/immunosuppression-model9e95e.jpg Immunosuppression Model https://si.prisysbiotech.com/uploads/39406/page/immunosuppression-model9e95e.jpg https://si.prisysbiotech.com/nhp-pharmacology/a-v-shunt-model.html A-V Shunt Model https://si.prisysbiotech.com/uploads/39406/a-v-shunt-modelef93d.jpg A-V Shunt Model https://si.prisysbiotech.com/uploads/39406/a-v-shunt-modelef93d.jpg https://si.prisysbiotech.com/nhp-pharmacology/type-1-diabetes-mellitus-model.html Type 1 Diabetes Mellitus Model https://si.prisysbiotech.com/uploads/39406/type-1-diabetes-mellitus-modelbc16f.png Type 1 Diabetes Mellitus Model https://si.prisysbiotech.com/uploads/39406/type-1-diabetes-mellitus-modelbc16f.png https://si.prisysbiotech.com/nhp-pharmacology/type-2-diabetes-mellitus-model.html Model sladkorne bolezni tipa 2 https://si.prisysbiotech.com/uploads/39406/type-2-diabetes-mellitus-model5981d.png Model sladkorne bolezni tipa 2 https://si.prisysbiotech.com/uploads/39406/type-2-diabetes-mellitus-model5981d.png https://si.prisysbiotech.com/nhp-pharmacology/endometriosis-model.html Endometriosis Model https://si.prisysbiotech.com/uploads/39406/endometriosis-modeldd994.png Endometriosis Model https://si.prisysbiotech.com/uploads/39406/endometriosis-modeldd994.png https://si.prisysbiotech.com/nhp-pharmacology/renal-fibrosis-model.html Renal Fibrosis Model https://si.prisysbiotech.com/uploads/39406/renal-fibrosis-modelb87a4.jpg Renal Fibrosis Model https://si.prisysbiotech.com/uploads/39406/renal-fibrosis-modelb87a4.jpg https://si.prisysbiotech.com/nhp-pharmacology/hyperlipoidemia-model.html Hyperlipoidemia Model https://si.prisysbiotech.com/uploads/39406/hyperlipoidemia-modeldc1b0.png Hyperlipoidemia Model https://si.prisysbiotech.com/uploads/39406/hyperlipoidemia-modeldc1b0.png https://si.prisysbiotech.com/clearpoint/nhp-neuroscience.html NHP Neuroscience https://si.prisysbiotech.com/uploads/39406/nhp-neuroscience94a5c.jpg NHP Neuroscience https://si.prisysbiotech.com/uploads/39406/nhp-neuroscience94a5c.jpg https://si.prisysbiotech.com/clearpoint/convection-enhanced-delivery-ced-technology.html Convection-Enhanced Delivery (CED) Technology https://si.prisysbiotech.com/uploads/39406/convection-enhanced-delivery-ced-technology7e74b.png Convection-Enhanced Delivery (CED) Technology https://si.prisysbiotech.com/uploads/39406/convection-enhanced-delivery-ced-technology7e74b.png https://si.prisysbiotech.com/nhp-pharmacology/atopic-dermatitis-nhp-model.html Atopic Dermatitis NHP Model https://si.prisysbiotech.com/uploads/39406/atopic-dermatitis-nhp-model0fc1f.jpg Atopic Dermatitis NHP Model https://si.prisysbiotech.com/uploads/39406/atopic-dermatitis-nhp-model0fc1f.jpg https://si.prisysbiotech.com/nhp-pharmacology/pruritus-nhp-model.html Pruritus NHP Model https://si.prisysbiotech.com/uploads/39406/pruritus-nhp-modelfcbdb.jpg Pruritus NHP Model https://si.prisysbiotech.com/uploads/39406/pruritus-nhp-modelfcbdb.jpg https://si.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-disease-ibd-nhp-model.html Inflammatory Bowel Disease IBD NHP Model https://si.prisysbiotech.com/uploads/39406/small/inflammatory-bowel-disease-ibd-nhp-model048b6.png Inflammatory Bowel Disease IBD NHP Model https://si.prisysbiotech.com/uploads/39406/inflammatory-bowel-disease-ibd-nhp-model048b6.png https://si.prisysbiotech.com/translation-research/targeted-organ-drug-delivery-platform-in-nhp.html Targeted Organ Drug Delivery Platform in NHP https://si.prisysbiotech.com/uploads/39406/targeted-organ-drug-delivery-platform-in-nhpe13f9.png Targeted Organ Drug Delivery Platform in NHP https://si.prisysbiotech.com/uploads/39406/targeted-organ-drug-delivery-platform-in-nhpe13f9.png https://si.prisysbiotech.com/nhp-pharmacology/aav-synuclein-overexpression-nhp-model.html AAV-α-Synuclein Overexpression NHP Model https://si.prisysbiotech.com/uploads/39406/small/aav-synuclein-overexpression-nhp-model93460.jpg AAV-α-Synuclein Overexpression NHP Model https://si.prisysbiotech.com/uploads/39406/aav-synuclein-overexpression-nhp-model93460.jpg https://si.prisysbiotech.com/nhp-pharmacology/heart-failure-nhp-model.html Heart Failure NHP Model https://si.prisysbiotech.com/uploads/39406/small/heart-failure-nhp-model8c759.jpg Heart Failure NHP Model https://si.prisysbiotech.com/uploads/39406/heart-failure-nhp-model8c759.jpg https://si.prisysbiotech.com/nhp-pharmacology/acute-lung-inflammation-ali-nhp-model.html Acute Lung Inflammation (ALI) NHP Model https://si.prisysbiotech.com/uploads/39406/page/small/acute-lung-inflammation-ali-nhp-modelcce6e.png Acute Lung Inflammation (ALI) NHP Model https://si.prisysbiotech.com/uploads/39406/page/acute-lung-inflammation-ali-nhp-modelcce6e.png https://si.prisysbiotech.com/pk-pd-adme/nose-to-brain-drug-delivery.html Nose-to-Brain Drug Delivery https://si.prisysbiotech.com/uploads/39406/small/nose-to-brain-drug-delivery15a9e.jpg Nose-to-Brain Drug Delivery https://si.prisysbiotech.com/uploads/39406/nose-to-brain-drug-delivery15a9e.jpg https://si.prisysbiotech.com/nhp-pharmacology/acute-hemorrhagic-shock-model-nhp-model.html Acute Hemorrhagic Shock Model NHP Model https://si.prisysbiotech.com/uploads/39406/small/acute-hemorrhagic-shock-model-nhp-model5b827.png Acute Hemorrhagic Shock Model NHP Model https://si.prisysbiotech.com/uploads/39406/acute-hemorrhagic-shock-model-nhp-model5b827.png https://si.prisysbiotech.com/nhp-pharmacology/retinitis-pigmentosa-rp-nhp-model.html Retinitis Pigmentosa (RP) NHP Model https://si.prisysbiotech.com/uploads/39406/small/retinitis-pigmentosa-rp-nhp-model49f0f.png Retinitis Pigmentosa (RP) NHP Model https://si.prisysbiotech.com/uploads/39406/retinitis-pigmentosa-rp-nhp-model49f0f.png https://si.prisysbiotech.com/nhp-pharmacology/liver-fibrosis-model.html Liver Fibrosis Model https://si.prisysbiotech.com/uploads/39406/small/liver-fibrosis-modelc2688.png Liver Fibrosis Model https://si.prisysbiotech.com/uploads/39406/liver-fibrosis-modelc2688.png https://si.prisysbiotech.com/pk-pd-adme/nhp-intracerebral-injection-icm-services.html NHP Intracerebral (ICM) Injection| Prisys Biotech https://si.prisysbiotech.com/uploads/39406/small/nhp-intracerebral-injection-icm-servicesbbf15.jpg NHP Intracerebral (ICM) Injection| Prisys Biotech https://si.prisysbiotech.com/uploads/39406/nhp-intracerebral-injection-icm-servicesbbf15.jpg https://si.prisysbiotech.com/translation-research/biodistribution-imaging-service.html Biodistribution Imaging Service https://si.prisysbiotech.com/uploads/39406/biodistribution-imaging-serviceabec3.png Biodistribution Imaging Service https://si.prisysbiotech.com/uploads/39406/biodistribution-imaging-serviceabec3.png https://si.prisysbiotech.com/pk-pd-adme/nhp-intrathecal-dosing-csf-sampling.html NHP Intrathecal (IT) Injection & CSF Sampling Services | Prisys Biotech https://si.prisysbiotech.com/uploads/39406/small/nhp-intrathecal-dosing-csf-samplingb3e80.png NHP Intrathecal (IT) Injection & CSF Sampling Services | Prisys Biotech https://si.prisysbiotech.com/uploads/39406/nhp-intrathecal-dosing-csf-samplingb3e80.png https://si.prisysbiotech.com/translation-research/dsa-guided-interventional-platform.html DSA-Guided Interventional Platform For NHP Research | Prisys Biotech https://si.prisysbiotech.com/uploads/39406/small/dsa-guided-interventional-platformb8fb1.png DSA-Guided Interventional Platform For NHP Research | Prisys Biotech https://si.prisysbiotech.com/uploads/39406/dsa-guided-interventional-platformb8fb1.png https://si.prisysbiotech.com/nhp-pharmacology/nhp-focal-segmental-glomerulosclerosis-fsgs.html Focal Segmental Glomerulosclerosis (FSGS) NHP Model https://si.prisysbiotech.com/uploads/39406/page/small/nhp-focal-segmental-glomerulosclerosis-fsgsd2851.jpg Focal Segmental Glomerulosclerosis (FSGS) NHP Model https://si.prisysbiotech.com/uploads/39406/page/nhp-focal-segmental-glomerulosclerosis-fsgsd2851.jpg https://si.prisysbiotech.com/pk-pd-adme/nhp-intracerebroventricular-icv-injection.html NHP Intracerebroventricular (ICV) Injection | Prisys Biotech https://si.prisysbiotech.com/uploads/39406/small/nhp-intracerebroventricular-icv-injectionccb4c.png NHP Intracerebroventricular (ICV) Injection | Prisys Biotech https://si.prisysbiotech.com/uploads/39406/nhp-intracerebroventricular-icv-injectionccb4c.png https://si.prisysbiotech.com/news/molecular-imaging-in-nhp-model-webinar-18003171801998336.html Molekularno slikanje v modelih NHP za translacijski razvoj zdravil https://si.prisysbiotech.com/uploads/39406/news/n20260817131455786a8.jpg https://si.prisysbiotech.com/news/nhp-behavioratlas-3d-behavioral-tracking-17969623434880000.html Spletni seminar NHP BehaviorAtlas|3D NHP vedenjsko sledenje za razvoj zdravil https://si.prisysbiotech.com/uploads/39406/news/n20260706130958536b1.png https://si.prisysbiotech.com/news/2025-recap-how-prisys-is-redefining-translati-17724350220346368.html Povzetek leta 2025: Kako Prisys na novo opredeljuje prevodno zanesljivost v raziskavi NHP https://si.prisysbiotech.com/uploads/39406/news/n20260115105444c1b0c.jpg https://si.prisysbiotech.com/news/nhp-based-pharmacology-and-pharmacodynamic-17562737527546880.html Farmakologija in farmakodinamične storitve na osnovi NHP -|Prisys Biotech https://si.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg https://si.prisysbiotech.com/news/meet-prisys-biotech-at-upcoming-eu-roadshow-17535314202141696.html Spoznajte Prisys Biotech na prihajajočem EU Roadshow: september 2025 https://si.prisysbiotech.com/uploads/39406/news/n2025082013335410dba.jpg https://si.prisysbiotech.com/news/prisys-biotech-2025-mid-year-review-17456117602345984.html Prisys Biotech-2025 Pregled sredi leta https://si.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg https://si.prisysbiotech.com/news/meet-prisys-in-2025-us-roadshow-17243291127882752.html Marca 2025 se srečajte s Prisys v prihajajočem ameriškem krogu. https://si.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg https://si.prisysbiotech.com/news/prisys-annual-report-2024-advancing-nhp-model-83977277.html Letno poročilo PRISYS 2024: Napredovanje modelov NHP in predkliničnih raziskav https://si.prisysbiotech.com/uploads/39406/news/n20241204135917ca94f.jpg https://si.prisysbiotech.com/news/prisys-biotech-2024-q2-newsletter-77783174.html Prisys Biotech 2024 Q2 Newsletter - Izboljšane predklinične raziskave in razvoj za terapevtike osrednjega živčevja z navzkrižno reaktivnimi modeli PRISYS https://si.prisysbiotech.com/uploads/39406/news/n20240520124055bc2de.png https://si.prisysbiotech.com/news/animal-models-succeed-or-fail-in-drug-dev-18028066728387584.html Zakaj živalski modeli uspejo ali ne uspejo pri razvoju zdravil https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/quantitative-pet-target-engagement-in-nhps-for-18021154087724032.html Kvantitativna ciljna vključitev PET v NHP za zdravila za CNS https://si.prisysbiotech.com/uploads/39406/news/n202608261535298f0fc.png https://si.prisysbiotech.com/news/3d-ai-tracking-nhp-behavior-18015241986253824.html Od videa do podatkov: 3D sledenje z umetno inteligenco za vedenje NHP https://si.prisysbiotech.com/uploads/39406/news/p2026082115534501025.png https://si.prisysbiotech.com/news/pet-biodistribution-nhp-studies-18015350125569024.html PET slikanje biodistribucije pri -nečloveških primatih https://si.prisysbiotech.com/uploads/39406/news/n202608191309007190a.png https://si.prisysbiotech.com/news/pbpk-vs-compartmental-models-drug-development-18003171814663168.html PBPK vs. Kompartmentalni modeli: Zakaj je PBPK pomemben https://si.prisysbiotech.com/uploads/39406/news/n20260814103950d26c5.jpg https://si.prisysbiotech.com/news/webinar-recap-digital-behavioral-phenotyping-17993149705626624.html Povzetek spletnega seminarja: Napredovanje translacijskih raziskav NHP prek digitalnega vedenjskega fenotipa https://si.prisysbiotech.com/uploads/39406/news/n20260807130040f7d24.png https://si.prisysbiotech.com/news/pk-biomarkers-preclinical-drug-development-17990412928394240.html PK biomarkerji v predkliničnem razvoju zdravil|Izpostavljenost–odziv in farmakokinetika/farmakodinamika https://si.prisysbiotech.com/uploads/39406/news/n20260805152832759f2.png https://si.prisysbiotech.com/news/behavior-in-rhesus-17985502798259200.html Spontano samo{0}}poškodbno vedenje pri Rhesus makakih: translacijski model NHP za razvoj nevropsihiatričnih zdravil https://si.prisysbiotech.com/uploads/39406/news/n20260731163230fd87d.png https://si.prisysbiotech.com/news/midd-and-nhp-efficacy-models-in-drug-17985502085964800.html Modela učinkovitosti MIDD in NHP pri razvoju translacijskih zdravil https://si.prisysbiotech.com/uploads/39406/news/n2026073013213937533.png https://si.prisysbiotech.com/news/markerless-3d-nhp-behavior-analysis-17977105930085376.html AI-Powered 3D NHP vedenjska analiza|Vedenjsko fenotipiziranje brez markerjev https://si.prisysbiotech.com/uploads/39406/news/n20260723161948c057f.png https://si.prisysbiotech.com/news/webinar-nhp-behavioratlas-17977105974289408.html Globalni spletni seminar|Kvantifikacija zapletenih vedenj NHP: Predstavljamo NHP BehaviorAtlas za visoko{0}}zanesljivo 3D vedenjsko fenotipizacijo https://si.prisysbiotech.com/uploads/39406/news/n20260721164252b91dc.jpg https://si.prisysbiotech.com/news/ai-nhp-behavioral-analysis-17969623459079168.html Vedenjska analiza NHP-za predklinični razvoj zdravil|Prisys Biotech https://si.prisysbiotech.com/uploads/39406/news/n202607171631204cfce.png https://si.prisysbiotech.com/news/when-to-introduce-nhp-studies-autoimmune-drug-17977106256045056.html Kdaj uvesti študije NHP pri razvoju avtoimunskih zdravil https://si.prisysbiotech.com/uploads/39406/news/n2026071314114600533.png https://si.prisysbiotech.com/news/nhp-ibd-model-chronic-enterocolitis-17977106349319168.html Modeli KVČB NHP: kaj nas kronični enterokolitis pri Rhesus Macaques nauči o translacijskem vnetju črevesja https://si.prisysbiotech.com/uploads/39406/news/n20260710141850796f6.png https://si.prisysbiotech.com/news/nhp-aav-gene-therapy-model-mri-guided-ced-17977105888846848.html MRI{0}}vodena dostava AAV v modelih možganov NHP za gensko terapijo CNS https://si.prisysbiotech.com/uploads/39406/news/n202607071035506b1ed.png https://si.prisysbiotech.com/news/why-positive-control-drugs-matter-in-autoimmun-17977106026652672.html Zakaj so zdravila za pozitivno kontrolo pomembna pri modelih avtoimunskih bolezni|Prisys Biotech https://si.prisysbiotech.com/uploads/39406/news/n202607011605210dd31.png https://si.prisysbiotech.com/news/baseline-ada-screening-washed-out-monkeys-17977105850803200.html Izhodiščno presejanje ADA pri izpranih-opicah za predklinične biološke študije https://si.prisysbiotech.com/uploads/39406/news/n2026062914295408abb.png https://si.prisysbiotech.com/news/pain-mechanisms-the-uvb-sunburn-model-17969623421297664.html Mehanizmi bolečine: model UVB sončnih opeklin je ključno translacijsko orodje https://si.prisysbiotech.com/uploads/39406/news/n202606261052354a6de.jpg https://si.prisysbiotech.com/news/nhp-models-of-maternal-high-fat-diet-and-child-17969623540966400.html Modeli NHP za materino prehrano z-maščobami in programiranje debelosti pri otrocih https://si.prisysbiotech.com/uploads/39406/news/n20260626101823325bd.jpg https://si.prisysbiotech.com/news/clinical-pathology-interpretation-dogs-nhp-17946854953640960.html Interpretacija klinične patologije pri psih in primatih razen človeka v predkliničnih študijah https://si.prisysbiotech.com/uploads/39406/news/n20260623143229ac184.jpg https://si.prisysbiotech.com/news/molecular-imaging-biomarkers-advancing-transl-17946854934144000.html Molekularni slikovni biomarkerji: pospeševanje translacijskih raziskav in razvoja zdravil https://si.prisysbiotech.com/uploads/39406/news/n202606181451278625b.png https://si.prisysbiotech.com/news/nonlinear-pharmacokinetics-explained-17946854981870592.html Kaj je nelinearna farmakokinetika? Mehanizmi, značilnosti in posledice za razvoj zdravil https://si.prisysbiotech.com/uploads/39406/news/n20260616141042be995.jpg https://si.prisysbiotech.com/news/nhp-molecular-imaging-translational-pet-studie-17946855138255872.html Zakaj je molekularno slikanje NHP kritično za translacijske študije PET https://si.prisysbiotech.com/uploads/39406/news/n202606121112387f111.jpg https://si.prisysbiotech.com/news/what-is-molecular-imaging-drug-development-17946855126213632.html Kaj je molekularno slikanje in zakaj je pomembno pri razvoju zdravil? https://si.prisysbiotech.com/uploads/39406/news/n2026061013321190d5a.jpg https://si.prisysbiotech.com/news/nhp-radionuclide-biodistribution-17946855213212672.html Študije biodistribucije radionuklidov NHP: Molekularno slikanje za translacijski razvoj zdravil https://si.prisysbiotech.com/uploads/39406/news/n2026060515134174d47.jpg https://si.prisysbiotech.com/news/nhp-heart-failure-model-17946855140697088.html Model srčnega popuščanja NHP podpira translacijske raziskave genske terapije za obnavljanje telomer https://si.prisysbiotech.com/uploads/39406/news/n20260602142703b954a.png https://si.prisysbiotech.com/news/dsa-cta-cardiovascular-drug-safety-imaging-17946855228761088.html Kako DSA in CTA slikanje izboljšata oceno varnosti zdravil za srce in ožilje https://si.prisysbiotech.com/uploads/39406/news/n2026052913380640f74.jpg https://si.prisysbiotech.com/news/nhp-av-shunt-thrombosis-model-17946854994011136.html Model tromboze arteriovenskega šanta NHP pri opicah Cynomolgus za oceno translacijskega antitrombotičnega zdravila https://si.prisysbiotech.com/uploads/39406/news/n20260527103349ad81a.jpg https://si.prisysbiotech.com/news/pk-data-as-translational-biomarker-17888394073187328.html Farmakokinetični podatki kot translacijski biomarker https://si.prisysbiotech.com/uploads/39406/news/n202605211329439d160.jpg https://si.prisysbiotech.com/news/non-human-primate-models-of-pulmonary-fibrosis-17888394067026944.html Ne-modeli pljučne fibroze pri primatih: izboljšanje translacijske natančnosti pri razvoju zdravil za dihala https://si.prisysbiotech.com/uploads/39406/news/n20260515153544ef082.jpg https://si.prisysbiotech.com/news/nhp-models-translational-drug-development-17888393995641856.html Zakaj je razvoj zdravil vse bolj odvisen od modelov NHP|Prisys Biotech https://si.prisysbiotech.com/uploads/39406/news/n20260514093832593bb.jpg https://si.prisysbiotech.com/news/pk-data-as-pharmacodynamic-biomarker-17888394166838272.html Podatki o farmakokinetiki kot farmakodinamični biomarker: napredek pri razvoju translacijskih zdravil s kvantitativno farmakologijo https://si.prisysbiotech.com/uploads/39406/news/n202605091519031a196.jpg https://si.prisysbiotech.com/news/non-glp-pharmacology-data-integrity-17853256132535296.html Ne-farmakološke študije GLP za regulativno predložitev: celovitost podatkov in laboratorijske zahteve https://si.prisysbiotech.com/uploads/39406/news/n20260424104846a67ea.jpg https://si.prisysbiotech.com/news/nonclinical-pharmacokinetics-strategy-17853256004838400.html Strateška zasnova nekliničnih farmakokinetičnih študij: od profiliranja ADME do translacijskega odločanja- https://si.prisysbiotech.com/uploads/39406/news/n202604201042394eb2f.jpg https://si.prisysbiotech.com/news/nhp-av-shunt-thrombosis-model-antibody-safety-17853255836722176.html NHP AV-model tromboze šanta za oceno varnosti zdravil|Prisys Biotech https://si.prisysbiotech.com/uploads/39406/news/n20260417154405f8553.jpg https://si.prisysbiotech.com/news/nonlinear-pharmacokinetics-nhp-pkpd-17853255970661376.html Kaj je nelinearna farmakokinetika? Mehanizmi in translacijska PK evalvacija|Prisys Biotech https://si.prisysbiotech.com/uploads/39406/news/n20260414144233849f1.png https://si.prisysbiotech.com/news/prisys-supports-ind-approval-of-ux-gip001-17853255933518848.html Prisys Biotech podpira IND odobritev UX-GIP001 s strani FDA in CDE|Platforma za dostavo NHP CNS https://img01.v15cdn.com/gallery/4x3/157.webp https://si.prisysbiotech.com/news/in-vivo-immune-cell-tracking-17853256148870144.html In vivo sledenje imunskim celicam in razvoj sledilnih PET v modelih NHP|Prisys Biotech https://si.prisysbiotech.com/uploads/39406/news/n202604021117547afde.jpg https://si.prisysbiotech.com/news/dopamine-transporter-pet-imaging-in-nhp-models-17853255976608768.html PET slikanje prenašalca dopamina v modelih NHP|Slikanje CNS|Prisys Biotech https://si.prisysbiotech.com/uploads/39406/news/n2026033113465773e8f.jpg https://si.prisysbiotech.com/news/pet-ct-biodistribution-in-nhp-models-for-cns-17853255819977728.html Biodistribucija PET/CT v modelih NHP za dostavo zdravil v CNS|Prisys Biotech https://si.prisysbiotech.com/uploads/39406/news/n202603271731432da82.jpg https://si.prisysbiotech.com/news/large-animal-radiolabeling-and-in-vivo-imaging-17853255811851264.html Velika-platforma za radioaktivno označevanje živali in slikanje in vivo za translacijski razvoj zdravil https://si.prisysbiotech.com/uploads/39406/news/n20260323111154bf8b7.jpg https://si.prisysbiotech.com/news/drug-development-reliance-on-nhp-models-17853255810507776.html Zakaj se razvoj zdravil vedno bolj opira na modele NHP: Bistvena vloga primatov v translacijski medicini|Prisys Biotech https://si.prisysbiotech.com/uploads/39406/news/n20260320115823340b4.png https://si.prisysbiotech.com/news/ipf-drug-development-nhp-ct-imaging-pft-17853255610377216.html Izzivi in ​​rešitve razvoja zdravil IPF|Modeli NHP s CT slikanjem in PFT https://si.prisysbiotech.com/uploads/39406/news/n2026031715015159514.png https://si.prisysbiotech.com/news/ai-markerless-nhp-3d-behavior-analysis-system-17853255632970752.html AI Markerless NHP 3D sistem za analizo vedenja za predklinične raziskave https://si.prisysbiotech.com/uploads/39406/news/n20260313142823bc65b.png https://si.prisysbiotech.com/news/evaluating-dmpk-properties-17853255731389440.html Vrednotenje lastnosti DMPK kandidatnih spojin pri zgodnjem odkrivanju zdravil|Prisys Biotech https://si.prisysbiotech.com/uploads/39406/news/n20260310153743383ae.jpg https://si.prisysbiotech.com/news/mri-guided-cns-delivery-in-nhp-models-17853255714989056.html MRI-Vodeni prenos osrednjega živčevja v modelih NHP|Prevajalska platforma IMRI & CED https://si.prisysbiotech.com/uploads/39406/news/n202602261246469558e.png https://si.prisysbiotech.com/news/nhp-cns-biodistribution-studies-intrathecal-17853242837935104.html Študije biodistribucije NHP CNS|Intratekalna dostava RNA|PRISYS biotehnologija https://si.prisysbiotech.com/uploads/39406/news/n20260214120241d2f33.jpg https://si.prisysbiotech.com/news/translational-pk-pd-framework-cynomolgus-17853242619995136.html Translacijski okvir farmakokinetike/farmakodinamike: napovedovanje odmerka opice Cynomolgus na človeka|Prisys Biotech https://si.prisysbiotech.com/uploads/39406/news/n20260213142144bd00d.png https://si.prisysbiotech.com/news/emotional-memory-chronic-pain-nhp-models-17724371490694144.html Ko bolečina postane spomin: čustveni dejavniki kronične bolečine in prednost modela NHP|Prisys Biotech https://si.prisysbiotech.com/uploads/39406/news/n2026012713131077473.jpg https://si.prisysbiotech.com/news/multi-endpoint-pain-assessment-the-future-17724350168982528.html Več{0}}ocenjevanje bolečine na končnih točkah: Prihodnost razvoja analgetikov https://si.prisysbiotech.com/uploads/39406/news/n20260123153636bce28.jpg https://si.prisysbiotech.com/news/analgesics-fail-in-preclinical-measure-pain-17724350205764608.html Zakaj toliko analgetikov ne uspe v predkliničnih preskušanjih? Odgovor je v tem, kako merimo bolečino https://si.prisysbiotech.com/uploads/39406/news/n20260120155944a4ef1.jpg https://si.prisysbiotech.com/news/blood-sampling-time-point-in-pharmacokinetic-17724350559249408.html Oblikovanje časovne točke vzorčenja krvi v farmakokinetičnih (PK) študijah|Prisys Biotech https://si.prisysbiotech.com/uploads/39406/news/n2026011316592151314.jpg https://si.prisysbiotech.com/news/pk-statistical-analysis-nca-parameters-guide-17724350543340544.html Farmakokinetična statistika: parametri ne{0}}kompartmentalne analize (NCA) in predklinične uporabe https://si.prisysbiotech.com/uploads/39406/news/n20260109161837141c9.jpg https://si.prisysbiotech.com/news/non-human-primate-models-are-critical-cns-17724350272447488.html Zakaj so modeli ne-človeških primatov kritični za terapevtiko oligonukleotidov CNS https://si.prisysbiotech.com/uploads/39406/news/n20260106130909b5b92.jpg https://si.prisysbiotech.com/news/uric-acid-metabolism-in-humans-vs-monkeys-17724350243300352.html Presnova sečne kisline pri ljudeh proti opicam: translacijske posledice za razvoj zdravil https://si.prisysbiotech.com/uploads/39406/news/2026010416213306463.jpg https://si.prisysbiotech.com/news/non-human-primate-mash-associated-liver-fibros-17724350154400768.html Model fibroze jeter, ki ni-povezan z MASH-človeškim primatom|Prisys Biotech https://si.prisysbiotech.com/uploads/39406/news/p20251226155519da3af.png https://si.prisysbiotech.com/news/imri-guided-brain-drug-delivery-17724350234895360.html Zakaj je IMRI-vodeno dajanje zdravil v možgane bistvenega pomena za natančno ciljanje v študijah NHP https://si.prisysbiotech.com/uploads/39406/news/n202512231619222564f.png https://si.prisysbiotech.com/news/ai-driven-markerless-3d-behavioral-analysis-17674911843230720.html 3D-analizni sistem NHP brez markerjev,-ki ga poganja umetna inteligenca|Prisys Biotech https://si.prisysbiotech.com/uploads/39406/news/n202512181608129079f.jpg https://si.prisysbiotech.com/news/lps-induced-acute-lung-inflammation-ali-nhp-17674911912780800.html Model NHP-povzročenega akutnega pljučnega vnetja (ALI)|Prisys Biotech https://si.prisysbiotech.com/uploads/39406/news/n202512161502375ccdb.jpg https://si.prisysbiotech.com/news/hdm-seb-induced-atopic-dermatitis-atd-model-17674911899853824.html Model HDM+SEB-induciranega atopičnega dermatitisa (AtD) pri opicah Cynomolgus https://si.prisysbiotech.com/uploads/39406/news/n20251212144449750c1.jpg https://si.prisysbiotech.com/news/one-to-multi-compartment-pk-models-17674912087286784.html Razlaga eno- do več-predelnih modelov PK|Farmakokinetika NHP|Prisys Biotech https://si.prisysbiotech.com/uploads/39406/news/n20251208140839d8db0.jpg https://si.prisysbiotech.com/news/how-to-choose-a-reliable-preclinical-cro-key-17674911813903360.html Kako izbrati zanesljivo predklinično CRO|Ključna merila za biotehnološka podjetja|Prisys Biotech https://si.prisysbiotech.com/uploads/39406/news/n20251204133731f364a.jpg https://si.prisysbiotech.com/news/translational-car-t-evaluation-in-vitro-17674911770682368.html Translacijsko vrednotenje CAR{0}}T: strokovno znanje in vitro in podpora študiji NHP – Prisys Biotech https://si.prisysbiotech.com/uploads/39406/news/n202512011123451e873.png https://si.prisysbiotech.com/news/cns-drug-candidates-in-preclinical-study-17674911783052288.html Zakaj več kot 90 % kandidatov za zdravila za CNS ne uspe v kliničnih preskušanjih? https://si.prisysbiotech.com/uploads/39406/news/n202511281410270841e.png https://si.prisysbiotech.com/news/parkinsons-disease-preclinical-models-17674911930426368.html Predklinični modeli Parkinsonove bolezni: vodnik za izbiro nevrotoksinskih, genetskih in NHP modelov|Prisys Biotech https://si.prisysbiotech.com/uploads/39406/news/n2025112415472074828.png https://si.prisysbiotech.com/news/high-precision-drug-delivery-and-ai-driven-nhp-17674911899067392.html Visoko-natančna dostava zdravil in-umetna inteligenca, prevajalske platforme NHP https://si.prisysbiotech.com/uploads/39406/news/n2025112108401436404.jpg https://si.prisysbiotech.com/news/th17-driven-nhp-immunology-models-17633147378377728.html Imunološki modeli NHP na podlagi Th17|Translacijske avtoimunske raziskave pri Prisys Biotech https://si.prisysbiotech.com/uploads/39406/news/n20251117110751844f3.png https://si.prisysbiotech.com/news/ai-based-nhp-behavioratlas-system-3d-behavi-17633229051814912.html Sistem NHP BehaviorAtlas®, ki temelji-na umetni inteligenci|Platforma za 3D vedenjsko analizo|Prisys Biotech https://si.prisysbiotech.com/uploads/39406/news/n20251114162428314a9.png https://si.prisysbiotech.com/news/rfp-template-for-nhp-studies-17633147492672512.html Predloga RFP za študije NHP|Pospešite učinkovitost predkliničnih raziskav https://si.prisysbiotech.com/uploads/39406/news/n2025111015483953c4b.jpg https://si.prisysbiotech.com/news/cold-allodynia-pain-model-in-cynomolgus-monkey-17633147342611456.html Model bolečine pri hladni alodiniji pri opicah Cynomolgus|Prisys Biotechnologies https://si.prisysbiotech.com/uploads/39406/news/n20251107160515acddb.jpg https://si.prisysbiotech.com/news/mri-guided-intracerebral-drug-delivery-17633147499701248.html MRI-Platforma za vodeno intracerebralno dostavo zdravil|Prisys Biotech CNS Research https://si.prisysbiotech.com/uploads/39406/news/n2025110514460235db1.jpg https://si.prisysbiotech.com/news/nhp-respiratory-disease-models-and-airway-drug-17633113635808256.html Modeli bolezni dihal NHP in platforma za dostavo zdravil v dihalnih poteh|Prisys Biotech https://si.prisysbiotech.com/uploads/39406/news/n20251028164336adaf3.png https://si.prisysbiotech.com/news/nhp-renal-biopsy-17633113603154944.html Platforma NHP za ledvično biopsijo in modeli bolezni ledvic|Prisys Biotech https://img01.v15cdn.com/gallery/4x3/276.webp https://si.prisysbiotech.com/news/pk-study-targeted-drug-delivery-17633113308980224.html Farmakokinetične študije in ciljna dostava zdravil|Prisys Biotech https://si.prisysbiotech.com/uploads/39406/news/n202510171638300dafe.jpg https://si.prisysbiotech.com/news/nhp-ai-based-behavioral-analysis-17633113286075392.html Prisys Biotechnologies' NHP Research and-Platforma za vedenjsko analizo na osnovi umetne inteligence https://si.prisysbiotech.com/uploads/39406/news/n2025101517485012ee9.jpg https://si.prisysbiotech.com/news/nasal-to-brain-n2b-delivery-technology-for-c-17633113189557248.html Tehnologija prenosa-v-možgane (N2B) za raziskave CŽS|Prisys Biotech https://si.prisysbiotech.com/uploads/39406/news/n20251011133522c7c7b.jpg https://si.prisysbiotech.com/news/shr-2004-a-breakthrough-in-vte-prevention-for-17633113050522624.html SHR-2004: Preboj pri preprečevanju VTE pri bolnicah z rakom jajčnikov – zgodba o uspehu Prisys Biotech https://si.prisysbiotech.com/uploads/39406/news/n2025101011280623985.jpg https://si.prisysbiotech.com/news/cynomolgus-rhesus-monkey-models-prisys-bio-17544964236207104.html Modeli opic Cynomolgus & Rhesus|Prisys Biotech Predclinical CRO https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/idiopathic-pulmonary-fibrosis-ipf-nhp-model-17535330823070720.html Model NHP idiopatske pljučne fibroze (IPF)|Prisys Biotech predklinični CRO https://si.prisysbiotech.com/uploads/39406/news/n20250912151948fd2c4.jpg https://si.prisysbiotech.com/news/cynomolgus-monkey-biodistribution-study-17535314226029568.html Študije biodistribucije opice Cynomolgus|Prisys Biotech Predclinical CRO https://si.prisysbiotech.com/uploads/39406/news/n202509091635226f118.jpg https://si.prisysbiotech.com/news/nhp-models-for-hematology-and-stroke-17535314345272320.html Prisys Biotech NHP modeli za raziskave hematologije in možganske kapi https://si.prisysbiotech.com/uploads/39406/news/n20250903101944cac91.jpg https://si.prisysbiotech.com/news/the-importance-of-administration-volume-17535314200634368.html Pomen obsega uporabe v predkliničnih študijah|Prisys Biotech https://si.prisysbiotech.com/uploads/39406/news/n202508261427201a2af.gif https://si.prisysbiotech.com/news/brain-targeted-drug-delivery-17535314106409984.html Možgani - Ciljna dostava zdravil|Prisys Biotech predklinične raziskave NHP https://si.prisysbiotech.com/uploads/39406/news/n202508221539309f4a5.jpg https://si.prisysbiotech.com/news/adc-drug-development-translational-pk-pd-fra-17535314279015424.html Razvoj zdravil ADC|Translacijski okvir farmakokinetike/farmakodinamike v predkliničnih študijah NHP https://si.prisysbiotech.com/uploads/39406/news/n2026062914295408abb.png https://si.prisysbiotech.com/news/nhp-pain-models-for-translational-drug-discove-17502661593490432.html NHP Modeli proti bolečinam za odkrivanje translacijskih zdravil|Prisys Biotech https://si.prisysbiotech.com/uploads/39406/news/n20250813095806db594.jpg https://si.prisysbiotech.com/news/serum-vs-plasma-choosing-the-optimal-matrix-17502661556691968.html Serum vs. Plazma: Izbira optimalne matrice za predklinično bioanalizo https://si.prisysbiotech.com/uploads/39406/news/n20250805095551af23f.jpg https://si.prisysbiotech.com/news/preclinical-dosing-guidelines-iv-po-volume-17502661516420096.html Predklinične smernice za odmerjanje: IV in PO volumen, PH in osmolarnost za natančno farmakokinetiko pri NHP in drugih vrstah https://si.prisysbiotech.com/uploads/39406/news/n20250731153850aa43a.jpg https://si.prisysbiotech.com/news/nhp-copd-model-17502661557462016.html Najboljši raziskovalni modeli in odličnost dihalne platforme by PRISYS https://si.prisysbiotech.com/uploads/39406/news/n20250730125053bd455.jpg https://si.prisysbiotech.com/news/nhp-acute-hemorrhage-model-17502661419852800.html NHP Akutni model krvavitve: ključno orodje za pospešitev novih hematoloških zdravil https://si.prisysbiotech.com/uploads/39406/news/n20250722163908bd854.png https://si.prisysbiotech.com/news/pruritus-research-il-31-nhp-itch-model-17502661366408192.html PRURITUS RAZISKOVANJE: IL-31-inducirani model NHP, ki ga povzroča IL-31 https://si.prisysbiotech.com/uploads/39406/news/n202504011023488ec4a.png https://si.prisysbiotech.com/news/a-guide-to-anti-drug-antibody-ada-assessment-17456117747442688.html Vodnik za oceno protiteles proti-zdravilom (ADA). https://img01.v15cdn.com/gallery/4x3/148.webp https://si.prisysbiotech.com/news/respiratory-therapies-prisys-biotech-s-integr-17456117196153856.html Respiratorne terapije: integrirana platforma NHP podjetja Prisys Biotech za predklinične raziskave https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/nhp-pain-models-accelerating-analgesic-drug-d-17456117436228608.html NHP Modeli bolečine: pospeševanje analgetičnega razvoja zdravil pri biotehniku Prisys https://si.prisysbiotech.com/uploads/39406/news/p20250704135241befde.png https://si.prisysbiotech.com/news/nhp-model-platforms-to-support-drug-developmen-17456117017125888.html Modelne platforme NHP za podporo razvoju zdravil pri zapletenih boleznih https://si.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg https://si.prisysbiotech.com/news/key-considerations-for-dosing-volume-17456117781603328.html Ključni pomisleki za količino odmerjanja, PH in formulacijo v živalskih modelih https://si.prisysbiotech.com/uploads/39406/news/n202506260936191360e.png https://si.prisysbiotech.com/news/engineered-exosomes-revolutionizing-drug-deli-17456117094818816.html Izdelani eksosomi: revolucionarna dostava zdravil za motnje osrednjega živčevja – predklinični vpogled podjetja Prisys Biotech https://img01.v15cdn.com/gallery/4x3/300.webp https://si.prisysbiotech.com/news/guiding-principles-for-animal-species-selectio-17456117057987584.html Vodilna načela za izbiro živalskih vrst v toksikoloških študijah zdravil nukleinskih kislin https://img01.v15cdn.com/gallery/4x3/148.webp https://si.prisysbiotech.com/news/prisys-biotech-s-advanced-dsa-and-imri-for-hem-17456117221155840.html DSA in IMRI podjetja Prisys Biotech za študije hematoloških, žilnih in ledvičnih bolezni https://si.prisysbiotech.com/uploads/39406/news/n20250610100231b6146.jpg https://si.prisysbiotech.com/news/cynomolgus-monkey-pain-models-17456117043422208.html Modeli bolečine opice Cynomolgus: Spodbujanje translacijskih raziskav za prebojno terapevtiko ionskih kanalov https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/advancing-atopic-dermatitis-research-prisys-b-17456118054577152.html Napredek Atopijskega dermatitisa Ra https://si.prisysbiotech.com/uploads/39406/news/n20250530142432192c3.jpg https://si.prisysbiotech.com/news/prisys-biotech-s-nhp-atopic-dermatitis-model-f-17456116984931328.html Model atopijskega dermatitisa pri biotehniku Prisys Biotech za razvoj anti-pruritskih zdravil https://si.prisysbiotech.com/uploads/39406/news/p20250527155048d3f8c.png https://si.prisysbiotech.com/news/designing-animal-studies-key-considerations-f-17374212376716288.html Načrtovanje študij na živalih: ključni dejavniki za uspeh predkliničnih raziskav https://img01.v15cdn.com/gallery/4x3/300.webp https://si.prisysbiotech.com/news/atopic-dermatitis-how-cynomolgus-monkey-model-17374212045136896.html Atopijski dermatitis: kako modeli opic Cynomolgus napredujejo natančne terapevtike https://si.prisysbiotech.com/uploads/39406/news/n2025052012503626be2.jpg https://si.prisysbiotech.com/news/asthma-research-why-non-human-primate-models-17374212027409408.html Raziskava astme: zakaj so modeli ne{0}}človeških primatov ključni za razvoj novih zdravil https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/aso-pharmacokinetics-absorption-17374256333857792.html Razumevanje farmakokinetike protismiselnih oligonukleotidov (ASO): ključni dejavniki pri absorpciji in porazdelitvi https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/nhp-inhalation-studies-for-biologics-prisys-17374212705788928.html Študije vdihavanja NHP za biološka zdravila: Specializirane predklinične storitve CRO PRISYS https://img01.v15cdn.com/gallery/4x3/300.webp https://si.prisysbiotech.com/news/advanced-preclinical-inhalation-studies-techn-17374256304022528.html Napredne predklinične inhalacijske študije: tehnične zmogljivosti in strokovnost pri Prisys Biotech https://img01.v15cdn.com/gallery/4x3/300.webp https://si.prisysbiotech.com/news/pharmacokinetics-pk-key-parameters-17374256259195904.html Razumevanje farmakokinetike (PK): ključni parametri in aplikacije pri razvoju zdravil https://si.prisysbiotech.com/uploads/39406/news/n2025042511302920eb4.webp https://si.prisysbiotech.com/news/intracerebroventricular-icv-injection-17374295970620416.html Intracerebroventrikularna (ICV) injekcija: Natančna dostava CNS za predklinične raziskave https://si.prisysbiotech.com/uploads/39406/news/n2025042210212390d49.jpg https://si.prisysbiotech.com/news/intracerebral-icm-injection-precision-targe-17374212104119296.html Intracerebralna (ICM) injekcija: Natančno ciljanje za terapevtiko osrednjega živčevja – predklinični vidiki https://img01.v15cdn.com/gallery/4x3/148.webp https://si.prisysbiotech.com/news/intrathecal-it-injection-a-direct-cns-deliv-17374256328827904.html Intratekalna (IT) injekcija: neposredna dobavna pot v CŽS za napredne terapije – predklinični premisleki https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/advancing-parkinson-s-disease-research-with-th-17374212045841408.html Napredovanje raziskav Parkinsonove bolezni z modelom NHP https://img01.v15cdn.com/gallery/4x3/300.webp https://si.prisysbiotech.com/news/preclinical-pk-pd-studies-nhp-models-17374256562349056.html Predklinične študije PK/PD in modeli NHP za razvoj zdravil|Prisys Biotech https://img01.v15cdn.com/gallery/4x3/300.webp https://si.prisysbiotech.com/news/targeting-interleukin-31-autoimmune-disease-17298461729678336.html Usmerjanje na interlevkin-31 (IL-31): Nova meja v razvoju zdravil za avtoimunske bolezni – modeli Prisys Biotech NHP za predklinične raziskave https://si.prisysbiotech.com/uploads/39406/news/n202504011023488ec4a.png https://si.prisysbiotech.com/news/nonclinical-immunotoxicity-assessment-strateg-17295201989059584.html Neklinična ocena imunotoksičnosti: strategija, ključni premisleki in izbira metode https://img01.v15cdn.com/gallery/4x3/232.webp https://si.prisysbiotech.com/news/microbial-testing-and-its-impact-on-nhp-17295201663738880.html Mikrobno testiranje in njegov vpliv na ne-človeške primate v predkliničnih študijah DMPK https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/cynomolgus-monkey-endometriosis-model-17295201652384768.html Model endometrioze opice Cynomolgus za napredovanje terapevtskih raziskav https://si.prisysbiotech.com/uploads/39406/news/n2025032013423376e5c.png https://si.prisysbiotech.com/news/membranous-nephropathy-model-17295201501930496.html Napredovanje razvoja zdravil za membransko nefropatijo (MN): modelna platforma Cynomolgus Monkey podjetja Prisys Biotech https://img01.v15cdn.com/gallery/4x3/148.webp https://si.prisysbiotech.com/news/pharmacokinetics-of-inhaled-drugs-17295201747543040.html Farmakokinetika inhalacijskih zdravil: sprememba paradigme od sistemske izpostavljenosti k pljučni izpostavljenosti https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/animal-models-for-womens-health-17295201525883904.html Prisys Biotech: živalski modeli za terapevtiko zdravja žensk https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/world-obesity-day-nhp-metabolic-models-17295201861526528.html Dan svetovne debelosti|Presys Biotech NHP Metabolični modeli: Napajanje razvoja terapij proti debelosti naslednje generacije https://si.prisysbiotech.com/uploads/39406/news/n2025030417050873614.png https://si.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-monkey-psoriasis-m-17295201566680064.html Model Cynomolgus opice PSSYSSYSYSY BIOTECH Model: Napredek predklinične ocene farmakodinamike https://si.prisysbiotech.com/uploads/39406/news/n202502280925537e8ce.jpg https://si.prisysbiotech.com/news/integration-of-pharmacokinetics-and-pharmacody-17295201478435840.html Vključevanje farmakokinetike in farmakodinamike pri razvoju zdravil https://si.prisysbiotech.com/uploads/39406/news/n2025022110272438f73.png https://si.prisysbiotech.com/news/on-demand-webinar-mri-ced-nhp-17888393996411904.html Spletni seminar na-zahtevo|Natančni most: MRI{1}}vodeni CED in prevedljivi modeli NHP za dostavo zdravil v CNS https://si.prisysbiotech.com/uploads/39406/news/n202604301806570fdec.jpg https://si.prisysbiotech.com/news/what-does-proof-of-concept-poc-in-drug-devel-17295201767056384.html Kaj v resnici potrjuje dokaz koncepta (PoC) pri razvoju zdravil? https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/animal-models-challenges-and-applications-in-17295201433052160.html Živalski modeli|Izzivi in ​​aplikacije pri razvoju modela bolečine https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/nonclinical-pharmacodynamic-research-17295201819223040.html Neklinične farmakodinamične raziskave https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/selecting-the-ideal-non-human-primate-for-toxi-17243291073520640.html Izbira idealnega ne{0}}človeškega primata za toksikološke študije: Cynomolgus Macaque, Rhesus Macaque in Marmoset https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/rtimri-for-parkinsons-disease-81254206.html Ciljna terapija za Parkinsonovo bolezen: preboj v-časovni MRI-vodeni presaditvi izvornih celic https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/systemic-lupus-erythematosus-sle-and-the-rol-17295201447601152.html Sistemski eritematozni lupus (SLE) in vloga živalskih modelov pri terapevtskem razvoju https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/non-human-primate-model-for-rheumatoid-arthrit-17295201446159360.html Model nečloveškega primata za revmatoidni artritis (RA) https://si.prisysbiotech.com/uploads/39406/news/n20250117153412b3280.jpg https://si.prisysbiotech.com/news/animal-brain-stereotactic-instruments-17295201494377472.html Stereotaktični instrumenti živalskih možganov, ki temeljijo na 3D koordinatnih sistemih https://si.prisysbiotech.com/uploads/39406/news/n20250115133928772c1.jpg https://si.prisysbiotech.com/news/animal-models-for-in-vivo-testing-1-establi-17295201824973824.html Živalski modeli za testiranje in vivo (1): Vzpostavitev in razvrstitev https://img01.v15cdn.com/gallery/4x3/148.webp https://si.prisysbiotech.com/news/potential-routes-for-biologics-to-brain-83977286.html Raziskovanje možnih poti za vstop bioloških zdravil v možgane https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/advancing-rheumatoid-arthritis-ra-research-w-83977282.html Napredovanje raziskav revmatoidnega artritisa (RA) z modeli primatov, ki niso človeški https://si.prisysbiotech.com/uploads/39406/news/n20250102143547c190f.jpg https://si.prisysbiotech.com/news/animal-models-for-atopic-dermatitis-83977355.html Raziskovanje učinkovitosti zdravil za atopijski dermatitis na živalskih modelih https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/the-critical-role-of-animal-models-in-human-di-83977276.html Ključna vloga živalskih modelov pri raziskavah človeških bolezni https://si.prisysbiotech.com/uploads/39406/news/n202412271723592a539.jpg https://si.prisysbiotech.com/news/parkin-gene-deficiency-monkey-model-reveals-ne-83978250.html Opičji model pomanjkanja gena Parkin razkriva nove mehanizme in terapevtske tarče za Parkinsonovo bolezen https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/nonclinical-drug-development-guide-toxicity-83977279.html Neklinični vodnik za razvoj zdravil: študije akutne, subakutne, subkronične in kronične splošne toksičnosti https://si.prisysbiotech.com/uploads/39406/news/n20241220112548bfcff.jpg https://si.prisysbiotech.com/news/nasal-to-brain-n2b-drug-delivery-83977290.html Inovativna dostava zdravil iz nosu v možgane (N2B): obvoz krvno-možganske pregrade https://si.prisysbiotech.com/uploads/39406/news/n202412161319158371d.jpg https://si.prisysbiotech.com/news/minipig-as-nonclinical-large-animal-83977275.html Priložnosti in izzivi mini prašičev kot neklinične velike živalske vrste https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/drug-delivery-strategies-for-brain-diseases-83048467.html Strategije dajanja zdravil za možganske bolezni https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/real-time-intraoperative-mri-navigation-suppo-83099033.html Intraoperativna MRI navigacija-v realnem času: podpora odobritvi FDA za prvo gensko terapijo za pomanjkanje AADC https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/ocular-toxicity-studies-of-eye-drops-drug-exp-83048928.html Študije očesne toksičnosti kapljic za oko: izpostavljenost zdravilu in ocena varnosti https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/prisys-biotech-establishes-cynomolgus-monkey-p-82741467.html Prisys Biotech vzpostavi model psoriaze Cynomolgus Monkey za pospešitev razvoja zdravil https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/comprehensive-non-human-primate-models-for-ren-82741878.html Obsežni modeli ne-človeških primatov za raziskave ledvične bolezni, Prisys Biotech https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/comprehensive-preclinical-safety-evaluation-of-82741463.html Celovita predklinična ocena varnosti konjugatov proti-zdravil (ADC) pri ne-človeških primatih https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/pharmacokinetics-evaluation-of-antibody-drug-c-82741464.html Farmakokinetična ocena konjugatov protiteles-zdravil (ADC) pri ne-človeških primatih https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/pharmacodynamics-evaluation-of-adcs-82741462.html Farmakodinamična ocena ADC https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/understanding-the-dmpk-of-adc-drugs-82741465.html Razumevanje DMPK zdravil ADC https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/progress-in-the-development-of-nucleic-acid-dr-82741469.html Napredek pri razvoju zdravil za nukleinske kisline in raziskovalne zmogljivosti Prisys Biotech https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/advances-in-mrna-pulmonary-delivery-systems-an-82282655.html Napredek v sistemih za dostavo mRNA v pljuča in inovativnih storitvah Prisys biotech https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/2024-nobel-prize-in-physiology-or-medicine-82741488.html Zakaj je bila Nobelova nagrada za fiziologijo ali medicino leta 2024 podeljena tema dvema znanstvenikoma, ki sta preučevala mikroRNA? https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/pharmacokinetic-pk-considerations-for-centra-82741466.html Farmakokinetični (PK) vidiki zdravil za centralni živčni sistem (CNS). https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/advancements-in-cns-research-ced-imri-79656510.html Napredek pri raziskavah osrednjega živčevja: MRI-združljiv sistem za vbrizgavanje v možgane podjetja Prisys Biotech in tehnologija CED https://si.prisysbiotech.com/uploads/39406/news/n20260818092955a6cca.jpg https://si.prisysbiotech.com/news/cynomolgus-monkey-mcao-model-81254209.html Napredovanje terapevtskih inovacij pri krvavitvah in strjevanju z modelom MCAO Cynomolgus Monkey https://si.prisysbiotech.com/uploads/39406/news/n202409241700121ed48.jpg https://si.prisysbiotech.com/news/dmpk-evaluation-of-central-nervous-system-cns-81254204.html DMPK vrednotenje zdravil za centralni živčni sistem (CNS). https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/animal-models-of-human-diseases-81254198.html Živalski modeli človeških bolezni https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/innovations-in-pain-evaluation-ai-driven-beha-81254200.html Inovacije pri ocenjevanju bolečine:-analiza vedenja na podlagi umetne inteligence https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/china-experimental-monkey-industry-81254199.html Zgodovina, trenutni status, izzivi in ​​priložnosti kitajske industrije eksperimentalnih opic https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/human-disease-animal-models-81254203.html Živalski modeli človeških bolezni: ključno orodje za napredek biomedicinskih raziskav https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/the-importance-of-preclinical-pharmacodynamics-81254205.html Pomen predklinične farmakodinamike pri razvoju zdravil|Prisys Biotech https://si.prisysbiotech.com/uploads/39406/news/n202608180930355ea9f.jpg https://si.prisysbiotech.com/news/intranasal-administration-in-animal-studies-81254218.html Intranazalno dajanje v študijah na živalih https://si.prisysbiotech.com/uploads/39406/news/n2026081809304573eca.jpg https://si.prisysbiotech.com/news/revolutionizing-cns-drug-development-prisys-b-79509972.html Revolucioniranje razvoja zdravil za CNS: PRISYS Biotech predstavlja tehnologijo IMRI https://si.prisysbiotech.com/uploads/39406/news/n20240729151529d56e9.png https://si.prisysbiotech.com/news/convection-enhanced-delivery-81254202.html Napredna natančna medicina: tehnologija konvekcijske-izboljšane dostave (CED) Prisys Biotech https://si.prisysbiotech.com/uploads/39406/news/n20260818093109a5b18.jpg https://si.prisysbiotech.com/news/cynomolgus-monkey-chronic-kidney-disease-model-81254201.html Model kronične ledvične bolezni (CKD) Cynomolgus Monkey podjetja Prisys Biotech https://si.prisysbiotech.com/uploads/39406/news/n20240820104326c1ab2.jpg https://si.prisysbiotech.com/news/nonclinical-safety-evaluation-of-ocular-drug-d-79556206.html Neklinična ocena varnosti očesne dostave zdravil z uporabo Cynomolgus Macaques https://si.prisysbiotech.com/uploads/39406/news/n2026081809313004e65.jpg https://si.prisysbiotech.com/news/compartment-pk-model-81254212.html Razumevanje kompartmentnih in ne{0}}kompartmentnih modelov v farmakokinetiki https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/advanced-cns-delivery-techniques-in-cynomolgus-81254208.html Napredne tehnike dostave CNS pri opicah Cynomolgus: pospeševanje razvoja oligonukleotidnih zdravil https://si.prisysbiotech.com/uploads/39406/news/n20260818093209f5a1f.jpg https://si.prisysbiotech.com/news/reducing-the-use-of-nonhuman-primates-in-noncl-79556212.html Zmanjšanje uporabe nečloveških primatov v nekliničnih ocenah varnosti: perspektive FDA in industrije https://si.prisysbiotech.com/uploads/39406/news/n20260818093218cb9d5.jpg https://si.prisysbiotech.com/news/lcms-preclinical-bioanalysis-of-lnp-based-gene-79556240.html LCMS predklinična bioanaliza zdravil za gensko terapijo na osnovi LNP- https://si.prisysbiotech.com/uploads/39406/news/n20260818093228e8ded.jpg https://si.prisysbiotech.com/news/mrna-based-therapies-past-79556236.html Terapije-na osnovi MRNA: Preteklost https://si.prisysbiotech.com/uploads/39406/news/n2026081809332814450.jpg https://si.prisysbiotech.com/news/pk-strategies-of-pdc-79556196.html Farmakokinetične študijske strategije konjugatov peptidnih-zdravil (PDC) https://si.prisysbiotech.com/uploads/39406/news/n20260818093337d1e36.jpg https://si.prisysbiotech.com/news/the-role-of-aav-in-gene-therapy-immune-respon-79556208.html Vloga AAV v genski terapiji: imunski odzivi in ​​toksičnost https://si.prisysbiotech.com/uploads/39406/news/n202608180933456edfc.jpg https://si.prisysbiotech.com/news/optimized-nonclinical-immunogenicity-evaluatio-79556210.html Optimizirane neklinične strategije vrednotenja imunogenosti https://si.prisysbiotech.com/uploads/39406/news/n20260818093356b38f2.jpg https://si.prisysbiotech.com/news/pharmacodynamic-pd-evaluation-of-gene-therap-79556244.html Farmakodinamična (PD) ocena genske terapije https://si.prisysbiotech.com/uploads/39406/news/n2026081809344882063.jpg https://si.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79556237.html Farmakokinetika in bioanaliza oligonukleotidnih zdravil-(1) https://si.prisysbiotech.com/uploads/39406/news/n202608180935436ab59.jpg https://si.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79556239.html Farmakokinetika in bioanaliza oligonukleotidnih zdravil: značilnosti absorpcije in farmakokinetike plazme (PK) https://si.prisysbiotech.com/uploads/39406/news/n2026081809363714d7b.jpg https://si.prisysbiotech.com/news/factors-to-consider-for-the-immunogenicity-of-79556238.html Dejavniki, ki jih je treba upoštevati pri imunogenosti oligonukleotidnih zdravil https://si.prisysbiotech.com/uploads/39406/news/n2026081809375929690.jpg https://si.prisysbiotech.com/news/mrna-a-powerful-and-versatile-tool-for-fighti-79556247.html MRNA: zmogljivo in vsestransko orodje za boj proti boleznim-Prisys-Biotech https://si.prisysbiotech.com/uploads/39406/news/n2026081809383817f03.jpg https://si.prisysbiotech.com/news/chinese-scientists-offers-new-strategies-to-re-79556224.html Kitajski znanstveniki ponujajo nove strategije za odpravo glavnih simptomov Parkinsonove bolezni https://si.prisysbiotech.com/uploads/39406/news/n20260818094028d7d16.jpg https://si.prisysbiotech.com/news/prisys-biotechnology-novel-lipid-nanoparticle-79556228.html Biotehnologija Prisys: novi lipidni nanodelci za dostavo MRNA v primatih https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/the-importance-of-translational-medicine-resea-79556225.html Pomen translacijskih medicinskih raziskav od osnovnih raziskav do kliničnih študij https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/the-main-factors-considered-in-woe-analysis-79556234.html Glavni dejavniki, upoštevani pri analizi WOE https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/how-to-deliver-biologics-to-the-brain-79556246.html Kako dostaviti biološka zdravila v možgane? https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/how-drugs-move-and-change-in-our-bodies-a-bri-79556221.html Kako se zdravila premikajo in spreminjajo v naših telesih: kratek uvod v farmakokinetiko https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/how-to-develop-new-drugs-faster-and-safer-a-g-79556227.html Kako hitreje in varneje razviti nova zdravila: vodnik po predkliničnih študijah DMPK https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/group-housing-guidelines-for-laboratory-monkey-79556230.html Smernice skupinske nastanitve za laboratorijske opice https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/the-vital-role-of-experimental-monkeys-in-adva-79556222.html Bistvena vloga poskusnih opic pri napredovanju znanstvenih raziskav https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/understanding-macaca-fascicularis-cynomolgus-79556229.html Razumevanje Macaca Fascicularis (Cynomolgus Monkey): ključne značilnosti in prispevki k biomedicinskim raziskavam https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/revolutionizing-metabolic-disease-treatment-a-79556213.html Revolucionarno zdravljenje presnovnih bolezni: napredek in izzivi pri razvoju peptidnih zdravil https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/how-to-evaluate-the-safety-of-skin-products-be-79556214.html Kako oceniti varnost izdelkov za kožo pred kliničnimi preskušanji? https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/the-significant-role-of-experimental-monkeys-i-79556232.html Pomembna vloga poskusnih opic pri razvoju inovativnih zdravil: notranji pogled na posel https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/liver-toxicity-as-a-key-concern-for-sirna-drug-79556231.html Toksičnost jeter kot ključna skrb za zdravila SiRNA: Celovita analiza Ciljna specifičnost: Dvorezen meč SiRNA https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/advancing-sirna-therapeutics-overcoming-chall-79556211.html Napredovanje terapevtike SiRNA: premagovanje izzivov pri razvoju zdravil https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/application-prospects-of-gene-drugs-based-on-l-79556245.html Možnosti uporabe genskih zdravil na osnovi lipidnih nanodelcev https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/key-points-in-designing-strategies-for-non-79556218.html Ključne točke pri oblikovanju strategij za ne-klinične študije na mladih živalih https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/insight-into-the-sensory-and-behavioral-traits-79556219.html Vpogled v senzorične in vedenjske lastnosti primatov razen človeka (NHP) https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/nonclinical-study-evaluation-q-a-79556226.html Vprašanja in odgovori o oceni neklinične študije https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/significance-principles-and-requirements-of-79556242.html Pomen, načela in zahteve varnostnih farmakoloških raziskav https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/how-to-evaluate-preclinical-pharmacological-ef-79556220.html Kako oceniti predklinično farmakološko učinkovitost? https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/reflections-on-non-clinical-pharmacology-studi-79556204.html Razmišljanje o ne-kliničnih farmakoloških študijah in vrednotenju terapevtskih zdravil za ne-alkoholni steatohepatitis (NASH) https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/advancing-cns-and-cgt-research-prisys-biotech-79556205.html Napredovanje raziskav CNS in CGT: Prisys Biotechnologies https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/non-human-primate-cerebrospinal-fluid-collecti-79556215.html Smernice za zbiranje cerebrospinalne tekočine ne-človeških primatov https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/considerations-for-interpreting-clinical-patho-79556209.html Premisleki za interpretacijo kliničnih patoloških podatkov pri primatih (NHP) in psih, ki niso-človeški https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/integrating-cns-safety-evaluation-into-79556201.html ​​​​​​​Vključevanje ocene varnosti CŽS v splošne toksikološke študije https://si.prisysbiotech.com/uploads/39406/news/n20260818092240ecd59.jpg https://si.prisysbiotech.com/news/how-to-conduct-preclinical-pharmacology-toxico-79556216.html Kako izvesti predklinično farmakološko/toksikološko oceno ADC? https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79556203.html ADME Insights For Oligonucleotide Drugs (1) - Absorpcija, Distribucija https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79556207.html ADME Insights For Oligonucleotide Drugs (2) - Presnova in izločanje https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/preclinical-animal-studies-1-animal-specie-79556197.html Predklinične študije na živalih (1) - živalske vrste https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/clinical-pathology-data-interpretation-challen-79556198.html Izzivi in ​​strategije pri interpretaciji kliničnih patoloških podatkov v predkliničnih študijah psov in primatov razen-človeka https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/preclinical-animal-studies-2-routes-and-vo-79556223.html Predklinične študije na živalih (2) - Poti in količine dajanja https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/mrna-based-therapies-present-79556243.html Terapije-na osnovi MRNA: Prisotne https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/mrna-based-therapies-future-and-challenges-79556241.html Terapije-na podlagi MRNA: prihodnost in izzivi https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/brief-introduction-about-biological-analysis-o-79556235.html Kratek uvod o biološki analizi genske terapije https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/cynomolgus-monkey-in-ophthalmic-drug-research-79510392.html Opica Cynomolgus v raziskavah oftalmoloških zdravil https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/prisys-nhp-models-immunology-inflammatio-79509971.html Translacijske in navzkrižne-reaktivne študije s Prisysovimi NHP modeli imunologije in vnetja https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/non-na-ve-nhps-in-preclinical-trials-a-cost-e-79205644.html Ne-naivni NHP v predkliničnih preskušanjih: stroškovno-učinkovita rešitev Prisys Biotech https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/nhp-asthma-model-79205630.html Model astme NHP: krepitev predkliničnih študij učinkovitosti zdravil s Prisys Biotech https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/advancing-immunology-and-inflammation-research-79205647.html Napredovanje raziskav imunologije in vnetja z modeli Cynomolgus Macaques - Prisys Biotechnologies https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/direct-delivery-of-oligonucleotide-drugs-to-th-79205628.html Neposredna dostava oligonukleotidnih zdravil v CNS in pogoste histopatološke spremembe https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/intra-cerebrovascular-stroke-ich-model-prisys-79205632.html Model intra-cerebrovaskularne kapi (ICH) družbe Prisys Biotech https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/non-clinical-pharmacodynamics-research-an-ess-75178502.html Ne-klinične farmakodinamične raziskave: Bistveni vidik pri razvoju zdravil SiRNA https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/mri-guided-large-animal-central-nervous-system-77783177.html MRI{0}}Vodeni sistem za natančno lokalizacijo in dostavo centralnega živčnega sistema velikih živali se namesti v Prisys Biotech https://si.prisysbiotech.com/uploads/39406/news/n2024042910594482ea8.jpg https://si.prisysbiotech.com/news/innovative-solutions-for-advancing-respiratory-77090716.html Inovativne rešitve za napredek respiratorne terapije https://si.prisysbiotech.com/uploads/39406/news/n202404261311431ebfc.jpg https://si.prisysbiotech.com/news/prisys-advancing-animal-experimentation-throu-74815207.html Prisys: Napredovanje poskusov na živalih s študijami Cynomolgus Macaque https://si.prisysbiotech.com/uploads/39406/news/n2026081810523468f50.jpg https://si.prisysbiotech.com/news/prisys-achieves-full-accreditation-from-aaalac-76237156.html Prisys pridobi polno akreditacijo AAALAC International: mejnik pri zagotavljanju visokih standardov oskrbe laboratorijskih živali. https://si.prisysbiotech.com/uploads/39406/news/n2026081810504717414.jpg https://si.prisysbiotech.com/news/elevating-nucleic-acid-therapeutics-through-cu-74703348.html Dvig terapevtike nukleinske kisline z najnovejšimi-dobnimi modeli Prisys Biotech nečloveških primatov https://si.prisysbiotech.com/uploads/39406/news/n202608181049206508e.jpg https://si.prisysbiotech.com/news/revolutionizing-cns-drug-delivery-prisys-and-74289838.html Revolucioniranje dostave zdravil v CNS: Prisys in obljuba intratekalne injekcije https://img01.v15cdn.com/gallery/4x3/148.webp https://si.prisysbiotech.com/news/nonhuman-primate-study-newsletter-2024-q-75178503.html Prisys Biotech 2024 Q1 Newsletter - vaš zanesljiv specialist za raziskave nečloveških primatov https://si.prisysbiotech.com/uploads/39406/news/n2024022009580247f09.jpg https://si.prisysbiotech.com/news/how-ultrasound-guided-liver-biopsy-enhances-ma-73807573.html Kako ultrazvočna-vodena biopsija jeter izboljša raziskave-na podlagi makakov https://si.prisysbiotech.com/uploads/39406/news/n20260818104547ef326.jpg https://si.prisysbiotech.com/news/guidelines-for-lifetime-use-of-nonhuman-primat-73807574.html Smernice za vseživljenjsko uporabo primatov razen človeka v biomedicinskih raziskavah: perspektiva biotehnologije Prisys https://si.prisysbiotech.com/uploads/39406/news/n202608181046546955c.jpg https://si.prisysbiotech.com/news/non-human-primates-a-brief-introduction-to-th-73030835.html Primati razen človeka: kratek uvod v njihove biološke značilnosti https://si.prisysbiotech.com/uploads/39406/news/n20260818104755a1151.jpg https://si.prisysbiotech.com/news/exhibition-review-prisys-biotech-shines-at-t-72713177.html Pregled razstave|Prisys Biotech blesti na letnem srečanju Ameriškega združenja za nevroznanost (SfN 2023) https://si.prisysbiotech.com/uploads/202339406/n202311211050557965049.jpg https://si.prisysbiotech.com/news/meet-prisys-biotech-at-the-society-for-neurosc-72331866.html Spoznajte Prisys Biotech na letnem srečanju Društva za nevroznanost (SfN 2023) https://si.prisysbiotech.com/uploads/202339406/n202311071007243112725.jpg https://si.prisysbiotech.com/news/world-stroke-day-focus-on-ischemic-stroke-an-72331865.html Svetovni dan možganske kapi|Osredotočite se na živalske modele ishemične kapi in farmakologijo https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/prisys-biotech-invites-you-to-attend-sapa-chin-72331863.html Prisys Biotech vas vabi, da se udeležite letnega srečanja SAPA-Kitajska leta 2023 https://si.prisysbiotech.com/uploads/202339406/n202310271316191263008.jpg https://si.prisysbiotech.com/news/world-alzheimer-s-day-the-challenges-and-sol-72331867.html Svetovni dan Alzheimerjeve bolezni|Izzivi in ​​rešitve za razvoj zdravil za AD https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-macaque-animal-mod-72331868.html Prisys Biotechov živalski model Cynomolgus Macaque pomaga pri razvoju novih antikoagulantnih zdravil https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/prisys-providing-high-quality-animal-experime-71013367.html Prisys: zagotavljanje visoko{0}}kakovostnih storitev poskusov na živalih za novo protitelo proti-koagulacijskemu faktorju XI BJTJ-1837 https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/method-for-establishing-a-cynomolgus-monkey-mo-71011490.html Metoda za vzpostavitev modela hipertrigliceridemije opice Cynomolgus in njena uporaba https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/pharmacology-main-parameters-and-significance-71011664.html Farmakologija: glavni parametri in pomen farmakokinetike (PK) https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/preclinical-pharmacology-evaluation-of-oncolyt-71011331.html Predklinična farmakološka ocena zdravil proti onkolitičnim virusom https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/0-71013119.html Kako lahko zdravila z majhno nukleinsko kislino spremenijo zdravljenje bolezni osrednjega živčevja: vpogledi Prisys Biotechnology, ponudnika modelov bolezni NHP https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/pharmacokinetics-research-strategies-and-case-71012566.html Farmakokinetika, raziskovalne strategije in študije primerov peptidnih zdravil https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/key-research-points-of-adc-drug-pk-69671249.html Ključne raziskovalne točke zdravila ADC PK https://img01.v15cdn.com/gallery/4x3/148.webp https://si.prisysbiotech.com/news/prisys-biotechnology-a-leader-in-nhp-cns-dise-69671668.html Prisys Biotechnology: Vodilna raziskovalna platforma za modeliranje bolezni osrednjega živčnega sistema NHP https://si.prisysbiotech.com/uploads/202339406/n202307252159358927114.jpg https://si.prisysbiotech.com/news/how-to-lose-weight-and-control-diabetes-with-g-69309336.html Kako shujšati in nadzorovati sladkorno bolezen z izdelki GLP-1 https://si.prisysbiotech.com/uploads/39406/news/n202608181233398a12e.jpg https://si.prisysbiotech.com/news/how-china-monkey-help-to-conduct-preclinical-r-69309318.html Kako China Monkey pomaga pri izvajanju učinkovitosti predkliničnih raziskav? https://si.prisysbiotech.com/uploads/39406/news/n20260818124638529d2.jpg https://si.prisysbiotech.com/news/what-is-the-efficiency-of-rnai-69309339.html Kakšna je učinkovitost RNAi? https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/large-animal-experiment-public-service-platfor-69309298.html Prisys Biotech Large Animal Experiment Platform Public Service: nizko-cenovna in visoko-učinkovita rešitev za velike poskuse na živalih https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/how-aav-gene-therapy-can-save-your-vision-the-69087536.html Kako lahko genska terapija AAV reši vaš vid: Najnovejša dognanja študij na primatih, ki niso-človeški https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/prisys-biotech-showcases-non-human-primate-mod-69083649.html Prisys Biotech na letnem srečanju Japonskega združenja za toksikologijo predstavlja platformo modela ne{0}}človeških primatov https://si.prisysbiotech.com/uploads/202339406/n202306272201578501988.jpg https://si.prisysbiotech.com/news/the-promising-future-of-aav-gene-therapy-in-no-69084318.html Obetavna prihodnost genske terapije AAV pri -nečloveških primatih https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/what-are-lipid-nanoparticles-for-gene-therapy-69084954.html Kaj so lipidni nanodelci za gensko terapijo? https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/prisys-biotech-invites-you-to-participate-in-t-69086327.html Prisys Biotech vas vabi k udeležbi na 50. letnem srečanju Japonskega združenja za toksikologijo (JSOT) https://si.prisysbiotech.com/uploads/202339406/n202306160930293342952.jpg https://si.prisysbiotech.com/news/immunotoxicity-test-drug-safety-evaluation-pr-69089162.html Test imunotoksičnosti, ocena varnosti zdravil-PRISYS BIOTECH https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/an-optimal-animal-model-of-ischemic-stroke-est-68333182.html Optimalni živalski model ishemične možganske kapi, ugotovljen z digitalno subtrakcijsko angiografijo-vodenega avtolognega tromba pri opicah Cynomolgus https://si.prisysbiotech.com/uploads/202339406/n202306051532328723304.jpg https://si.prisysbiotech.com/news/why-you-should-care-about-non-human-primates-68128320.html Zakaj bi morali skrbeti za ne-človeške primate v raziskavah in razvoju sistema za dostavo zdravil nukleinske kisline https://si.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://si.prisysbiotech.com/news/meet-prisys-biotech-at-70th-jalas-68128317.html Spoznajte Prisys Biotech na 70. JALAS 2023! https://si.prisysbiotech.com/uploads/202339406/n202305232011515935612.jpg https://si.prisysbiotech.com/news/gene-therapy-shines-with-new-approvals-for-rar-68128328.html Genska terapija blesti z novimi odobritvami za redke bolezni https://si.prisysbiotech.com/uploads/39406/news/n20260818112227f0067.jpg https://si.prisysbiotech.com/news/revolutionizing-drug-discovery-nhp-68128316.html Revolucionarno odkrivanje zdravil: Kako nečloveški primati optimizirajo presejanje SiRNA za hitrejše in učinkovitejše rezultate https://si.prisysbiotech.com/uploads/39406/news/n2026081811211728443.jpg https://si.prisysbiotech.com/news/maximizing-sirna-pharmacology-efficiency-67584423.html Povečanje farmakološke učinkovitosti SiRNA z raziskavami nečloveških primatov https://si.prisysbiotech.com/uploads/39406/news/n202608181110261d729.jpg https://si.prisysbiotech.com/news/how-nonhuman-primates-can-revolutionize-sirna-67561376.html Kako lahko nečloveški primati revolucionirajo raziskave SiRNA: obsežen vodnik https://si.prisysbiotech.com/uploads/39406/news/n202608181109402926c.jpg https://si.prisysbiotech.com/news/celebrating-world-day-for-laboratory-animals-67584421.html Praznovanje svetovnega dneva laboratorijskih živali: zakaj je Prisys zavezan spodbujanju zdravja primatov razen človeka https://si.prisysbiotech.com/uploads/202339406/n202304242046033664975.jpg https://si.prisysbiotech.com/news/maximizing-crispr-cas9-research-efficiency-wit-67561377.html Povečanje raziskovalne učinkovitosti CRISPR/Cas9 z modeli nečloveških primatov https://si.prisysbiotech.com/uploads/39406/news/n20260818110815e127c.jpg https://si.prisysbiotech.com/news/unleashing-the-therapeutic-potential-67571050.html Sprostitev terapevtskega potenciala: zakaj je vlaganje v zdravila za nukleinske kisline prihodnost medicine https://si.prisysbiotech.com/uploads/39406/news/n202608181107339a708.jpg https://si.prisysbiotech.com/news/unlocking-the-potential-of-nonhuman-primates-67574793.html Sprostitev potenciala nečloveških primatov pri izboljšanju odkrivanja ciljev zdravil za gensko terapijo https://si.prisysbiotech.com/uploads/39406/news/n202608181106513ac69.jpg https://si.prisysbiotech.com/news/world-parkinsons-disease-day-67571971.html Združite se za Parkinsonovo bolezen: združimo roke za ozaveščanje ob svetovnem dnevu Parkinsonove bolezni https://si.prisysbiotech.com/uploads/202339406/n202304111648126878455.jpg https://si.prisysbiotech.com/news/nhp-effectively-in-gene-therapy-67579496.html Kako učinkovito uporabiti ne-človeške primate pri vrednotenju varnosti genske terapije https://si.prisysbiotech.com/uploads/39406/news/n20260818110521065c0.jpg https://si.prisysbiotech.com/news/gene-therapy-toxicology-66276569.html Toksikološke raziskave genske terapije s primatom Nonhuam https://si.prisysbiotech.com/uploads/39406/news/n202608181102082f663.jpg https://si.prisysbiotech.com/news/dmpk-study-for-gene-therapy-66153784.html Obsežen vodnik za izvajanje študije DMPK za gensko terapijo https://si.prisysbiotech.com/uploads/39406/news/n20260818110117c7822.jpg https://si.prisysbiotech.com/news/gene-therapy-nhp-model-66153780.html Revolucioniranje medicinskih raziskav: Preboji genske terapije pri modelih bolezni primatov, ki niso človeški! https://si.prisysbiotech.com/uploads/39406/news/n20260818105650617bb.jpg https://si.prisysbiotech.com/news/top-10-popular-questions-related-to-gene-thera-66153783.html 10 najbolj priljubljenih vprašanj v zvezi z gensko terapijo https://si.prisysbiotech.com/uploads/39406/news/n20260818105726b2641.jpg https://si.prisysbiotech.com/news/prisys-biotech-non-human-primate-pharmacology-66153781.html Prisys Biotech: Farmakologija ne-človeških primatov za gensko terapijo https://si.prisysbiotech.com/uploads/39406/news/n20260818105536d2837.jpg https://si.prisysbiotech.com/news/supporting-women-s-health-a-look-into-endomet-66153782.html Podpora zdravju žensk: pogled na endometriozo https://si.prisysbiotech.com/uploads/202339406/n202303080917443223214.jpg https://si.prisysbiotech.com/news/prisys-sot2023-66153778.html PRISYS in Taichu Group sodelujeta za razstavo SOT leta 2023 https://si.prisysbiotech.com/uploads/202339406/n202303101009207805940.jpg https://si.prisysbiotech.com/news/do-we-need-further-studies-for-pain-assessment-66153777.html Ali potrebujemo nadaljnje študije za oceno bolečine? - NHP https://si.prisysbiotech.com/uploads/39406/news/n20260818105333c5854.jpg https://si.prisysbiotech.com/news/prisys-celebrating-world-wildlife-day-66153779.html Pridružite se nam pri praznovanju svetovnega dneva prostoživečih živali https://si.prisysbiotech.com/uploads/202339406/n202303031713469632535.jpg https://si.prisysbiotech.com/news/the-construction-of-prisys-shanghai-nhp-r-d-ce-66153776.html Začetek centra za raziskave in razvoj Prisys Shanghai NHP, ki pomeni mejnik v farmacevtskih raziskavah in razvoju na Kitajskem https://si.prisysbiotech.com/uploads/202339406/n202303081340054460581.jpg https://si.prisysbiotech.com/news/meetprisys-sot2023-66276566.html Meet Prisys @ Booth No. 1434 in The Upcoming SOT Conference | US-Roadshow https://si.prisysbiotech.com/uploads/202339406/n202303031705254453292.jpg